A pan-cancer CAF marker remains elusive and podoplanin (PDPN) in pancreatic ductal adenocarcinoma (PDAC) may be the only consistent, disease-specific CAF marker identified in cancer to-date [114,115]. This evidence concerns the gene PDPN and cancer.